Literature DB >> 35261469

Phantosmia and dysgeusia as the first presentation of glioblastoma.

Atef Kokash1, John Emil Carlson1.   

Abstract

Glioblastoma is the most common and aggressive primary brain tumor in adults and has an extremely poor prognosis. It is rare for a high-grade glioma, or any brain tumor, to have an initial presentation of gastrointestinal symptoms. We present a rare case of a healthy 70-year-old woman who presented with symptoms of phantosmia and dysgeusia with magnetic resonance imaging findings of a brain mass confirmed via brain biopsy to be glioblastoma. Through a rare presentation, we aim to elucidate the importance of recognizing the association of phantosmia and dysgeusia to seizure auras and the critical need for diagnostic imaging to rule out organic causes such as infection and neoplasms.
Copyright © 2021 Baylor University Medical Center.

Entities:  

Keywords:  Dysgeusia; glioblastoma; glioma; grade IV glioma; phantosmia; seizure

Year:  2021        PMID: 35261469      PMCID: PMC8865230          DOI: 10.1080/08998280.2021.1990703

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  3 in total

1.  Patterns of care for adults with newly diagnosed malignant glioma.

Authors:  Susan M Chang; Ian F Parney; Wei Huang; Frederick A Anderson; Anthony L Asher; Mark Bernstein; Kevin O Lillehei; Henry Brem; Mitchel S Berger; Edward R Laws
Journal:  JAMA       Date:  2005-02-02       Impact factor: 56.272

2.  Polysomy of chromosomes 1 and 19: an underestimated prognostic factor in oligodendroglial tumors.

Authors:  Haihui Jiang; Xiaohui Ren; Zhe Zhang; Wei Zeng; Junmei Wang; Song Lin
Journal:  J Neurooncol       Date:  2014-07-10       Impact factor: 4.130

Review 3.  Dysphasia and phantosmia as first presentation of multifocal cerebral anaplastic astrocytomas: case report and review of the literatures.

Authors:  Xiangyi Kong; Yu Wang; Shuai Liu; Zhaohui Lu; Huanwen Wu; Xinxin Mao; Xin Cheng; Jun Gao; Jian Guan; Yi Yang; Yongning Li; Bing Xing; Wenbin Ma; Renzhi Wang
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.